chartexchange

Investor Alert: Robbins LLP Informs Investors of the EyePoint, Inc. Class Action Lawsuit

Business Wire | Nov 18, 2026 2:23 AM EST

SAN DIEGO--(BUSINESS WIRE)---- $EYPT #EYPT--EyePoint allegedly misled investors regarding the efficacy and viability of DURAVYU for the treatment of wet age-related macular degeneration.

Read original article